Comparing Physician and Patient Perspectives on Prophylactic Treatment with BAY 94-9027 for Severe Haemophilia A: A Post Hoc Analysis
ConclusionInterviewed physicians and patients generally agreed on the beneficial impact of BAY 94-9027, specifically regarding the increased level of self-confidence in patients and its subsequent positive impact on patients’ lives. These findings supported the observed improvement on the Haemo-QoL-A emotional impact subscale. Overall, this study highlights the concordance between physici an and patient perspective on the positive experience with BAY 94-9027.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Drugs & Pharmacology | Haemophilia | Hemophilia | Israel Health | Middle East Health | Netherlands Health | Study